HORMONE CONNECTION ESTROGEN REBALANCE
Natural health product licensed in Canada
- Licence holder
- IHH Products Division Inc.
- NPN or DIN-HM
- 80070836
- Status
- Inactive licence
- Licence date
- 5 July 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme Potency : 0.5 % Agnuside | 100 milligramme | Not calculated |
| Sel de calcium acide d-Glucarique (1:1) Source : Saccharate de calcium | 75 milligramme | Not calculated |
| 3-hydroxyméthylindole Source : Indole-3-carbinol | 75 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme Potency : 50 % Epigallocatechin 3-gallate | 50 milligramme | Not calculated |
| Rosmarinus officinalis Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme | 50 milligramme | Not calculated |
| Curcuma longa Source : Rhizome Extraction ratio : 40:1 Dry plant equivalent : 1,000 milligramme Potency : 95 % Curcuminoids | 25 milligramme | Not calculated |
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 25 milligramme | Not calculated |
| Brassica oleracea var. italica Source : Graine(s) Extraction ratio : 8:1 Dry plant equivalent : 120 milligramme Potency : 15 milligramme Glucoraphanin | 15 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as a hormone normalizer to help stabilize menstrual cycle irregularities.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070836
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.